Searchable abstracts of presentations at key conferences in endocrinology

ea0066p28 | Diabetes 2 | BSPED2019

Using quality improvement (QI) to improve the care pathway and outcomes for children newly diagnosed with type I diabetes mellitus

Coxson Edward , Edmonds Clare , Diskin Lynn , Purcell Gillian , Kyprios Hannah , Carter Hayley , Fong Rey , Gupta Vineeta , Bradshaw Karen , Vass Clare , Bird Laura , Zatchij Anna , Edwards Helen

Background: Early glycaemic control improves long-term outcomes in children with Type I diabetes. The NICE target for children with T1DM is HbA1c ≤ 48 mmol/mol. 2018 data from our newly diagnosed patients (pre-QI) demonstrated mean HbA1c 50 mmol/mol at 3 months and 62 mmol/mol at 12 months.Aims and methods: Our aim is to improve average blood glucose levels at day 28 post diagnosis and achieve a median HbA1c of <48 mmol/mol at 3 and 12 months p...

ea0068oc2 | Abstracts | UKINETS2019

Development of ex-vivo models of metastatic neuroendocrine neoplasms

Doornebal Ewald , Harris Nicola , Edwards Helen , Miquel Rosa , Zen Yoh , Pizanias Michail , Prachalias Andreas , Menon Krishna , Zamalloa Ane , Preziosi Melissa , Heaton Nigel , Ramage John K , Williams Roger , Palma Elena , Chokshi Shilpa , Srirajaskanthan Raj

Background: The lack of relevant in-vivo and in-vitro models has precluded investigations of the pathophysiology of metastatic NENs. Organotypic tumour slices retain the complexity of tumours in-vivo without extensive manipulation of the tissue. The aims of this study are to understand the utility of precision cut slice technology to develop an immunocompetent model of metastatic GEP NENs to test new therapeutics and elucidate immunological, molecula...